Lantheus Biosciences LTD.
England Life Molecular Imaging, LIMITED
- UEI
- FKMRJTNYMPZ1
- CAGE
- U13Y8
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
- HQ8QAZN1L2C4
-
- SAM.gov registration date
- Physical address
- Arena Business Centre, 25 Barnes Wallis Rd, Fareham PO15 5TS, UK
- Website
- lantheus.com
- Founded
- 1956
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $60,000 |
| FY2024 | $188,300 |
| FY2023 | $146,000 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Chesapeake Medical Imaging | — | 621512 Diagnostic Imaging Centers |
| Cellsight Technologies, Inc. | San Francisco, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| IBA Molecular | Sterling, VA | 325412 Pharmaceutical Preparation Manufacturing |
| Scantox Neuro GMBH | Grambach, Steiermark | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Einsenca Inc. | Kennett Square, PA | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Life Molecular Imaging LIMITED is a for-profit corporate entity headquartered in the United Kingdom, registered in SAM.gov since 2016, with expertise in manufacturing radiopharmaceuticals and molecular imaging technologies. The company specializes in producing FDA-approved amyloid and tau protein positron emission tomography (PET) radioligand doses, which are critical for advanced medical research focused on understanding brain pathology and aging processes. Positioned as a parent organization, Life Molecular Imaging LIMITED operates from its Arena Business Centre location in Fareham, UK, and maintains a operational presence in Sterling, Virginia to support federal government contract work.
The company has consistently provided specialized imaging services to federal health research agencies, primarily the National Institute on Aging (NIA) and the National Institute of Mental Health (NIMH). Their federal contract awards have been predominantly focused on delivering precise medical research materials, including specific quantities of amyloid and tau protein PET radioligand doses. These contracts, ranging from $43,900 to $90,000, have supported critical research initiatives like the Baltimore Longitudinal Study of Aging. None of the company's federal contract awards have included set-aside designations, and they have been awarded as firm fixed-price delivery orders or purchase orders, demonstrating a straightforward and targeted approach to fulfilling federal research requirements.
Life Molecular Imaging LIMITED holds a significant single award indefinite delivery contract with the National Institute on Aging valued at $1,900,000, with an ultimate completion date of September 14, 2028. This primary indefinite delivery vehicle (IDV) is specifically designed to support the acquisition of FDA-approved amyloid and second-generation tau PET radioligand doses for measuring brain pathology. Task orders issued to date under this IDV have totaled approximately $146,000, covering tau protein PET imaging services and amyloid doses. The contract directly supports the NIA's mission of understanding aging processes and extends the agency's capability to characterize longitudinal brain changes through advanced molecular imaging techniques, positioning Life Molecular Imaging LIMITED as a critical research partner in neurological and aging studies.
Quick answers
Is Lantheus Biosciences LTD. registered in SAM.gov?
Yes. Lantheus Biosciences LTD.'s SAM.gov registration is active through May 17, 2027.
What is Lantheus Biosciences LTD.'s CAGE code?
Lantheus Biosciences LTD.'s CAGE code is U13Y8, and its Unique Entity ID (UEI) is FKMRJTNYMPZ1.
How much has Lantheus Biosciences LTD. received in federal contracts?
Federal contracts obligated $60,000 to Lantheus Biosciences LTD. in fiscal year 2025 and $394,300 in fiscal years 2023 through 2027.
What is Lantheus Biosciences LTD.'s most recent federal award?
Lantheus Biosciences LTD.'s most recent federal contract award is The purpose of this delivery order is for the contractor to provide 40 FDA-approved amyloid pet radioligand doses (75N95025F00001), from National Institute on Drug Abuse (NIH), on September 15, 2025.
On GovTribe
See Lantheus Biosciences LTD.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors